Intravenous and oral dosing of a directacting and reversible P2Y12 inhibitor

Details for Australian Patent Application No. 2008247483 (hide)

Owner Portola Pharmaceuticals, Inc.

Inventors Hutchaleelaha, Athiwat; Wolin, Huang; Pandey, Anjali; Phillips, David R.; Gretler, Daniel D.; Conley, Pamela B.; Andre, Patrick; Scarborough, Robert M.

Agent Davies Collison Cave

Pub. Number AU-A-2008247483

PCT Pub. Number WO2008/137753

Priority 60/915,649 02.05.07 US; 60/947,921 03.07.07 US

Filing date 2 May 2008

Wipo publication date 13 November 2008

International Classifications

A61K 31/216 (2006.01)

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

26 November 2009 PCT application entered the National Phase

  PCT publication WO2008/137753 Priority application(s): WO2008/137753

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008247488-Amino acid lipids and uses thereof

2008247480-Apparatus and method for producing concrete